Literature DB >> 20193031

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

N Tajik1, F Shahsavar, M Nasiri, M F Radjabzadeh.   

Abstract

Natural killer (NK) cells eliminate infected and transformed cells while still are self-tolerant. Interactions of the independently segregating Killer cell immunoglobulin-like receptors (KIR) and human leucocyte antigens (HLA) loci play a critical role in NK cell regulation. Different compound KIR-HLA genotypes can impart different thresholds of activation to the NK-cell repertoire and such genotypic variation has been found to confer altered risk in a number of human diseases including viral infections, autoimmune disorders, reproduction abnormalities and cancers. In this study, we presented a novel combined KIR-HLA polymerase chain reaction-sequence-specific primers genotyping assay for simultaneous determination of KIR genes and their three major HLA class I ligand groups (C1, C2, and Bw4). Moreover, known inhibitory and activating KIR + HLA (iKIR + HLA: 2DL2/3 + C1, 2DL1 + C2, 3DL1 + Bw4; and aKIR + HLA: 2DS2 + C1, 2DS1 + C2, 3DS1 + Bw4) combinations as well as co-inheritance of aKIR genes and iKIR + HLA pairs were analysed in a total of 200 unrelated healthy Iranian individuals. All tested subjects had at least one of the three iKIR + HLA pairs and the frequencies of various inhibitory combinations in the study group were: 31.5%, three iKIR + HLA pairs, 53.5%, two iKIR + HLA pairs, and 15%, 0ne iKIR + HLA pair. Furthermore, we revealed that majority of Iranians (69%) carry compound genotypes with greater number of inhibitory pairings than activating combinations (iKIR + HLA > aKIR + HLA). Conversely, iKIR + HLA < aKIR (45%) was dominant genotype in the study group. We conclude that selective evolutionary pressure has propensity to maintain KIR-HLA genotypes with more inhibitory combinations to guarantee self-tolerance. In contrast, existence of activating KIR genes without normal endogenous ligands, potentially arms the NK population for competent immunosurveillance and stronger defense against infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193031     DOI: 10.1111/j.1744-313X.2010.00906.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  21 in total

1.  Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.

Authors:  Suliman Y Alomar; Afrah Alkhuriji; Paul Trayhyrn; Abdulkarim Alhetheel; Abdullah Al-Jurayyan; Lamjed Mansour
Journal:  Immunogenetics       Date:  2016-09-15       Impact factor: 2.846

2.  KIR : HLA association with clinical manifestations of HBV infection in Madurai, south India.

Authors:  Narayanan Kalyanaraman; Lakshmikanthan Thayumanavan; Mariakuttikan Jayalakshmi
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

3.  The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.

Authors:  Alireza Shah-Hosseini; Mohammad Jafari; Asadollah Mohammadi; Roozbeh Sanaei; Seyed Moayed Alavian; Amin Doosti-Irani; Mehrnoush Nooradeh Keykavousi; Nader Tajik
Journal:  Med Microbiol Immunol       Date:  2017-10-14       Impact factor: 3.402

4.  Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.

Authors:  Mahdi Mahmoudi; Faranak Fallahian; Soheila Sobhani; Shima Ghoroghi; Ahmadreza Jamshidi; Shiva Poursani; Masoumeh Dolati; Zahra Hosseinpour; Farhad Gharibdoost
Journal:  Clin Rheumatol       Date:  2017-01-24       Impact factor: 2.980

5.  Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.

Authors:  Negin Farzamikia; Seyyedeh Mina Hejazian; Mehdi Haghi; Seyyed Sina Hejazian; Sepideh Zununi Vahed; Mohammadreza Ardalan
Journal:  Immunogenetics       Date:  2022-01-29       Impact factor: 2.846

6.  Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.

Authors:  Suwit Chaisri; Kriengkrai Kitcharoen; Amornrat V Romphruk; Arunrat Romphruk; Campbell S Witt; Chanvit Leelayuwat
Journal:  Immunogenetics       Date:  2013-06-29       Impact factor: 2.846

7.  Colorectal cancer and the KIR genes in the human genome: A meta-analysis.

Authors:  Koroush Ghanadi; Bahareh Shayanrad; Seyyed Amir Yasin Ahmadi; Farhad Shahsavar; Hossein Eliasy
Journal:  Genom Data       Date:  2016-11-01

8.  Analysis of the expression of KIR and HLA-Cw in a Northeast Han population.

Authors:  Yu Han; Ling Zhao; Zhenyu Jiang; Ning Ma
Journal:  Exp Ther Med       Date:  2012-10-25       Impact factor: 2.447

9.  Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population.

Authors:  Suliman Y Al Omar; Afrah Alkuriji; Saleh Alwasel; Javid Ahmed Dar; Alwaleed Alhammad; Stephen Christmas; Lamjed Mansour
Journal:  Genet Mol Biol       Date:  2016-03       Impact factor: 1.771

10.  Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis.

Authors:  Masoumeh Nazari; Mahdi Mahmoudi; Farzaneh Rahmani; Masoomeh Akhlaghi; Maani Beigy; Maryam Azarian; Elmira Shamsian; Maryam Akhtari; Reza Mansouri
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.